Impact of prognostic factor distributions on mortality disparities for socioeconomically disadvantaged cancer patients

Author(s):  
Yan Lu ◽  
Aaron W. Gehr ◽  
Kalyani Narra ◽  
Anuradha Lingam ◽  
Bassam Ghabach ◽  
...  
2020 ◽  
Author(s):  
Emre Yekedüz ◽  
Elif Berna Köksoy ◽  
Hakan Akbulut ◽  
Yüksel Ürün ◽  
Güngör Utkan

Aim: Using circulating tumor DNA (ctDNA) instead of historical clinicopathological factors to select patients for adjuvant chemotherapy (ACT) may reduce inappropriate therapy. Material & methods: MEDLINE was searched on March 31, 2020. Studies, including data related to the prognostic value of ctDNA in the colon cancer patients after surgery and after ACT, were included. The generic inverse-variance method with a random-effects model was used for meta-analysis. Results: Four studies were included for this meta-analysis. ctDNA-positive colon cancer patients after surgery and ACT had a significantly increased risk of recurrence compared with ctDNA-negative patients. Conclusions: ctDNA is an independent prognostic factor, and this meta-analysis is a significant step for using ctDNA instead of historical prognostic factors in the adjuvant setting.


2021 ◽  
Vol 32 ◽  
pp. S118-S119
Author(s):  
J. Tandiono ◽  
E. Marcella ◽  
S. Chen ◽  
C. Jonatan ◽  
R. Heriyanto ◽  
...  

2004 ◽  
Vol 112 (6) ◽  
pp. 1015-1019 ◽  
Author(s):  
Liselotte Dahlgren ◽  
Hanna (Mellin) Dahlstrand ◽  
David Lindquist ◽  
Anders Högmo ◽  
Linda Björnestål ◽  
...  

2007 ◽  
Vol 9 (4) ◽  
Author(s):  
Javier Silva ◽  
Vanesa García ◽  
José M García ◽  
Cristina Peña ◽  
Gemma Domínguez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document